Skip to main content
Clinical Trials/NCT00643656
NCT00643656CompletedPhase 4

Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion

Air Liquide Santé International1 site in 1 country94 target enrollmentStarted: October 2007Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
94
Locations
1
Primary Endpoint
Pain measurement by using Visual Analog Scale (VAS)

Study Overview

Brief Summary

A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment. This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in this clinical protocol.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patient requiring a liver biopsy of focal lesion
  • Age upper than 18 years
  • OMS : 0 to 3
  • patient consent form signed

Exclusion Criteria

  • patient unable to use Visual Analog Scale (VAS)
  • OMS upper than 3
  • coagulation disorder
  • contraindication linked to the experimental product
  • patient already included in another clinical trial uncompatible with this trial

Arms & Interventions

A

Experimental

Mixture of 50% nitrous oxide and 50% oxygen

Intervention: Kalinox 170 bar (Drug)

B

Placebo Comparator

Mixture of 50% oxygen and 50% nitrogen

Intervention: Mix of 50% oxygen and 50% nitrogen (Drug)

Outcomes

Primary Outcomes

Pain measurement by using Visual Analog Scale (VAS)

Time Frame: At the end of the liver biospy

Secondary Outcomes

  • Patient's acceptance and doctor's satisfaction(At the end of the liver biopsy)

Investigators

Sponsor
Air Liquide Santé International
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials